Target Name: MIR3907
NCBI ID: G100500835
Other Name(s): hsa-mir-3907 | hsa-miR-3907 | MicroRNA 3907 | microRNA 3907

MIR3907: A Potential Drug Target and Biomarker

Molecular Intelligence Research (MIR) has identified a potential drug target and biomarker for the treatment of various diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases. The target, named MIR3907, is a protein that is expressed in high levels in cancer cells and has been associated with the development of multiple diseases.

The discovery of MIR3907 as a potential drug target and biomarker was made through a combination of in vitro and in vivo experiments. The in vitro experiments were performed using cancer cell lines, including human breast cancer (HBC) cells, which are often used as a model for cancer research. The results of these experiments demonstrated that MIR3907 was highly expressed in HBC cells and that it was associated with the growth and survival of these cells.

In addition to its expression in cancer cells, MIR3907 was also shown to be expressed in normal tissues and cells, including brain, heart, and liver cells. This suggests that it may be a potential biomarker for various diseases, including cancer.

The potential drug target for MIR3907 is its role in cell signaling. Specifically, MIR3907 is a protein that is involved in the regulation of cell signaling pathways, including the TGF-β pathway. This pathway is involved in the development and maintenance of tissues and organs, as well as in the regulation of cell growth and differentiation.

MIR3907 has been shown to play a role in the regulation of TGF-β signaling in cancer cells. TGF-β is a protein that is involved in the development and maintenance of tissues and organs, as well as in the regulation of cell growth and differentiation. MIR3907 has been shown to help regulate the activity of TGF-β, which is critical for the growth and survival of cancer cells.

The potential drug target for MIR3907 is its ability to inhibit the activity of TGF-β. This is an important finding because TGF-β is often activated in cancer cells, which allows them to grow and survive without checks. By inhibiting TGF-β activity, MIR3907 may be able to inhibit the growth and survival of cancer cells.

In addition to its potential as a drug target, MIR3907 may also be a useful biomarker for the diagnosis and monitoring of various diseases. For example, MIR3907 may be used as a biomarker for cancer, as its expression is often increased in cancer cells. It may also be used as a biomarker for neurodegenerative disorders, as MIR3907 has been shown to be involved in the regulation of brain development and function.

The identification of MIR3907 as a potential drug target and biomarker for various diseases makes it an important finding with implications for the development of new treatments. Further research is needed to fully understand the role of MIR3907 in cell signaling and its potential as a drug target and biomarker.

Overall, the discovery of MIR3907 as a potential drug target and biomarker is a promising finding with implications for the development of new treatments for a variety of diseases. Further research is needed to fully understand its role in cell signaling and its potential as a drug target and biomarker.

Protein Name: MicroRNA 3907

More Common Targets

MIR3908 | MIR3909 | MIR3910-1 | MIR3910-2 | MIR3911 | MIR3912 | MIR3913-1 | MIR3913-2 | MIR3914-1 | MIR3914-2 | MIR3915 | MIR3916 | MIR3917 | MIR3918 | MIR3919 | MIR3920 | MIR3921 | MIR3922 | MIR3923 | MIR3924 | MIR3925 | MIR3926-1 | MIR3926-2 | MIR3927 | MIR3928 | MIR3929 | MIR3934 | MIR3935 | MIR3936 | MIR3936HG | MIR3937 | MIR3938 | MIR3939 | MIR3940 | MIR3941 | MIR3942 | MIR3943 | MIR3944 | MIR3945 | MIR3945HG | MIR3960 | MIR3972 | MIR3973 | MIR3974 | MIR3976 | MIR3976HG | MIR3977 | MIR3978 | MIR409 | MIR410 | MIR411 | MIR412 | MIR421 | MIR422A | MIR423 | MIR424 | MIR425 | MIR4251 | MIR4252 | MIR4253 | MIR4254 | MIR4255 | MIR4256 | MIR4257 | MIR4258 | MIR4259 | MIR4260 | MIR4261 | MIR4262 | MIR4263 | MIR4264 | MIR4265 | MIR4266 | MIR4267 | MIR4268 | MIR4269 | MIR4270 | MIR4271 | MIR4272 | MIR4273 | MIR4274 | MIR4275 | MIR4276 | MIR4277 | MIR4278 | MIR4279 | MIR4280 | MIR4281 | MIR4282 | MIR4283-1 | MIR4283-2 | MIR4284 | MIR4285 | MIR4286 | MIR4287 | MIR4288 | MIR4289 | MIR429 | MIR4290 | MIR4291